Telomerase assays in the diagnosis and prognosis of cancer

CIBA Foundation Symposia

Volumn , Issue 211, 1997, Pages 148-159

  Shay, Jerry W ^a   Werbin, Harold ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TUMOR MARKER;

CANCER INVASION; ENZYMOLOGY; HUMAN; IN SITU HYBRIDIZATION; METABOLISM; NEOPLASM; PATHOLOGY; PROGNOSIS; REVIEW; UPREGULATION;

HUMANS; IN SITU HYBRIDIZATION; NEOPLASM INVASIVENESS; NEOPLASMS; PROGNOSIS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0031304011     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR 1995 Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240-4248
2. Chiu C-P, Dragowska W, Kim NW et al 1996 Differential expression of telomerase activity in hemopoietic progenitors from adult human bone marrow. Stem Cells 14:239-248
3. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S 1995 Telomerase activity in normal leukocytes and hematologic malignancies. Blood 85:2315-2320
4. Feng J, Funk WD, Wang S-S et al 1995 The RNA component of human telomerase. Science 269:1236-1241
5. Harley CB, Villeponteau B 1995 Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5:249-255
6. Harley CB, Vaziri H, Counter MC, Allsopp RC 1992 The telomere hypothesis of cellular aging. Exp Gerontol 27:375-382
7. Hiyama K, Hirai Y, Kyoizumi S et al 1995a Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711-3715
8. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW 1995b Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1:249-255
9. Hiyama E, Yokoyama T, Tatsumoto N et al 1995e Telomerase activity in gastric cancer. Cancer Res 55:3258-3262
10. Hiyama E, Gollahon L, Kataoka T et al 1996a Telomerase activity in human breast tumors. J Natl Cancer Inst 88:116-122
11. Hiyama E, Gollahon L, Kataoka T et al 1996b Telomerase activity in human breast tumors. J Natl Cancer Inst 88:839-840
12. Hiyama E, Hiyama K, Tatsumoto N, Shay JW, Yokoyama T 1996c Telomerase activity in human intestine. Int J Oncol 9:453-458
13. Hiyama E, Kodama T, Shinbara K et al 1997 Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57:326-331
14. Holt SE, Norton JC, Wright WE, Shay JW 1996a Comparison of telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 17:1-15
15. Holt SE, Wright WE, Shay JW 1996b Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16:2932-2939
16. Kim NW, Piatyszek MA, Prowse KR et al 1994 Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015
17. Langford LA, Piatyszek MA, Xu R, Schuld SC, Wright WE, Shay JW 1997 Telomerase activity in ordinary meningiomas predicts poor outcome. Human Pathol 28:416-420
18. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ 1991 In vivo loss of telomeric repeats with age in humans. Mutat Res 256:45-48
19. Mao L, El-Naggar AK, Fan Y-H et al 1996 Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 56:5600-5603
20. Murnane JP, Sabatier L, Marder BA, Morgan WF 1994 Telomere dynamics in an immortal human cell line. EMBO J 13:4953-4962
21. Norrback KF, Dahlenborg K, Carlsson R, Roos G 1996 Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphoma. Blood 88:222-229
22. Piatyszek MA, Kim NW, Weinrich SL et al 1995 Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17:1-15
23. Sharma HW, Sokoloski JA, Perez JR et al 1995 Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92:12343-12346
24. Shay JW, Wright WE 1989 Quantitation of the frequency of immortalization of normal diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 184:109-118
25. Shay JW, Wright WE 1996a Telomerase activity in human cancer. Curr Opin Oncol 8:66-71
26. Shay JW, Wright WE 1996b The reactivation of telomerase activity in cancer progression. Trends Genet 12:129-130
27. Shay JW, Bacchetti S 1997 A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791
28. Shay JW, Gadzar AF 1997 Telomerase in the early detection of cancer. J Clin Pathol 50:106-109
29. Shay J W, Van Der Haegen BA, Ying Y, Wright WE 1993a The frequency of immortalization of human fibroblast and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 209:45-52
30. Shay JW, Wright WE, Werbin H 1993b Loss of telomeric DNA during aging may predispose cells to cancer. Int J Oncol 3:559-563
31. Shay JW, Werbin H, Wright WE 1996c Telomeres and telomerase in human leukemias. Leukemia 10:1255-1261
32. Van Der Haegen DA, Shay JW 1993 Immortalization of human mammary epithelial cells by SV40 large T-antigen involves a two-step mechanism in vitro. Cell Dev Biol 29:180-182
33. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM 1994 Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860
34. Wang S-S, Zakian VA 1990 Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature 345:456-458
35. Wright WE, Pereira-Smith OM, Shay JW 1989 Reversible cellular senescence. A two-stage model for the immortalization of normal human diploid fibroblasts. Mol Cell Biol 9:3088-3092
36. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW 1996 Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179
37. Yashima K, Piatyszek MA, Saboorian HM et al 1997 Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 50:110-117
38. Zhang W, Piatyszek MA, Kobayashi T et al 1996 Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 2:799-8031